3 Gao Q Y, Wang Z H, Hao E Y, et al. A novel model might predict the risk of chronic atrophic gastritis: a multicenter prospective study in China. Scand J Gastroenterol, 2012, 47: 509-517
[2]
4 Chen H M, Weng Y R, Jiang B, et al. Colonoscopy findings of colorectal adenoma and cancer in symptomatic patients in china between 1990 and 2009. J Digest Dis, 2011, 12: 371-378
[3]
5 Martinez M E, Baron J A, Lieberman D A, et al. A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology, 2009, 136: 832-841
[4]
6 Wang P, Wang Y C, Chen X Y, et al. CTHRC1 is upregulated by promoter demethylation and TGF-β1 and may associated with metastasis in human gastric cancer. Cancer Sci, 2012, 103: 1027-1033
[5]
7 Wang P, Fang J Y. XRCC1 down-regulated through promoter hypermethylation is involved in human gastric carcingenesis. J Digest Dis, 2010, 11: 343-351
[6]
8 Du W, Wang S, Zhou Q, et al. ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer. Oncogene, 2013, 32: 3319-3328
[7]
9 Tian X Q, Sun D F, Zhao S L, et al. ZNF278, a potential oncogene in human colorectal cancer. Acta Biochim Biophys Sin, 2008, 40: 289-296
[8]
10 Fang J Y, Chen Y X, Lu J, et al. Epigenetic modification regulates expression of tumor-associated genes and cell cycle in human colon cancer cell lines Colo-320 and SW1116. Cell Res, 2004, 13: 217-226
[9]
11 Fu L, Chen L, Yang J, et al. HIF-1α-induced histone demethylase JMJD2B contributes to the malignant phenotype of colorectal cancer cells via an epigenetic mechanism. Carcinogenesis, 2012, 33: 1664-1673
[10]
12 Tang J T, Wang J L, Hong J, et al. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer. Carcinogenesis, 2011, 32: 1207-1215
[11]
13 Cui Y, Su W Y, Xing J, et al. MiR-29a inhibits cell proliferation and induces cell cycle arrest through the downregulation of p42.3 in human gastric cancer. PLoS One, 2011, 6: e25872
[12]
14 Zhang Z, Li Z, Gao C, et al. miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest, 2008, 88: 1358-1366
[13]
15 Gao C, Zhang Z, Liu W, et al. Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer. Cancer, 2010, 116: 41-49
[14]
16 Su W Y, Li J T, Cui Y, et al. Bidirectional regulation between WDR83 and its natural antisense transcript DHPS in gastric cancer. Cell Res, 2012, 22: 1374-1389
[15]
17 Fang J Y, Richardson B C. The MAPK signaling pathway and human colorectal cancer. Lancet Oncol, 2005, 6: 322-327
[16]
18 Lu R, Wang X, Chen Z F, et al. Inhibition of the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway decrease DNA methylation in colon cancer cells. J Biol Chem, 2007, 282: 12249-12259
[17]
19 Zhao S L, Hong J, Xie Z Q, et al. TRAPPC4-ERK2 interaction activates ERK1/2, modulates its nuclear localization and regulates proliferation and apoptosis of colorectal cancer cells. PLoS One, 2011, 6: e23262
[18]
20 Weng Y R, Kong X, Yu Y N, et al. The role of ERK2 in colorectal carcinogenesis is partly regulated by TRAPPC4. Mol Carcinogen, 2013, doi 10.1002/mc.22031
[19]
21 Kong X, Qian J, Chen L S, et al. Synbindin contributes to malignant phenotypes of gastric cancer by activating ERK on the Golgi. J Natl Cancer Inst, 2013, 105: 1738-1749
[20]
22 Xiong H, Zhang Z G, Tian X Q, et al. Inhibition of JAK1, JAK2 and STAT3 signaling induces apoptosis, cell cycle arrest and reduces tumor cell invasion in colorectal cancer cells. Neoplasia, 2008, 10: 287-297
[21]
23 Xiong H, Du W, Wang J L, et al. Constitutive activation of STAT3 is predictive of poor prognosis in human gastric cancer. J Mol Med, 2012, 90: 1037-1046
[22]
24 Xiong H, Zhang Z G, Liang Q C, et al. Inhibition of STAT5 induces G1 cell cycle arrest and reduces tumor cell invasion in human colorectal cancer cells. Lab Invest, 2009, 89: 717-725
[23]
25 Du W, Wang Y C, Su W Y, et al. STAT5 isoforms play important role in colorectal cancer preferentially associated with STAT5b. J Cell Physiol, 2012, 227: 2421-2429
[24]
26 Du W, Hong J, Wang Y C, et al. Inhibition of JAK2/STAT3 signaling induces colorectal cancer cell apoptosis via mitochondrial pathway. J Cell Mol Med, 2012, 16: 1878-1888
[25]
27 Xiong H, Du W, Lin Y W, et al. Crosstalk between STAT3 signaling and COX-2 in Helicobacter pylori-associated human gastric tumorigenesis. Int J Cancer, 2013, doi: 10.1002/ijc.28539
[26]
28 Xiong H, Hong J, Du W, et al. Roles of STAT3 and ZEB1 in E-cadherin downregulation and human colorectal cancer epithelial-mesenchymal transition. J Biol Chem, 2012, 287: 5819-5832
[27]
29 Xiong H, Chen Z F, Liang Q C, et al. Inhibition of DNA methyltransferase induces G2 cell cycle arrest and apoptosis in human colorectal cancer cells via inhibition of JAK2/STAT3/STAT5 signaling. J Cell Mol Med, 2009, 13: 3668-3679
[28]
30 Xiong H, Du W, Zhang Y J, et al. Trichostatin A, a histone deacetylase inhibitor, suppresses JAK2/STAT3 signaling via inducing the promoter-associated histone acetylation of SOCS1 and SOCS3 in human colorectal cancer cells. Mol Carcinogen, 2012, 51: 174-184
[29]
31 Lin Y W, Ren L L, Xiong H, et al. Role of STAT3 and vitamin D receptor in EZH2-mediated invasion of human colorectal cancer. J Pathol, 2013, 230: 277-290
[30]
32 Xu J, Zhou X, Wang J, et al. RhoGAPs attenuate cell proliferation by direct interaction with p53 tetramerization domain. Cell Rep, 2013, 3: 1526-1538
[31]
33 Zhang Y J, Zhao S L, Dai Q, et al. Combined inhibition of Dnmt and mTOR signaling inhibits formation and growth of colorectal cancer. Int J Colorectal Dis, 2009, 24: 629-639
[32]
34 Zhang Y J, Dai Q, Tian X Q, et al. mTOR signal pathway is a target for the treatment of colorectal cancer. Ann Surg Oncol, 2009, 16: 2617-2628
2 Chooi E Y H, Chen H M, Shen L, et al. Chronic atrophy gastritis is a progressive disease: an analysis reports in Shanghai, China from 1985~2009. Singapore Med J, 2012, 53: 318-324
[35]
35 Lu R, Wang X, Sun D F, et al. Folic acid and sodium butyrate prevent tumorigenesis in a mouse model of colorectal cancer. Epigenetics, 2008, 3: 330-335
[36]
36 Lin Y W, Wang J L, Chen H M, et al. Folic acid supplementary reduce the incidence of adenocarcinoma in a mouse model of colorectal cancer: microarray gene expression profile. J Exp Clin Cancer Res, 2011, 30: 116
[37]
37 Chen H M, Lin Y W, Wang J L, et al. Butyrate-regulated genes in dimethylhydrazine-induced colorectal cancer in mice. Nutr Cancer, 2013, 65: 1171-1183
[38]
38 Xiao S D, Meng X J, Shi Y, et al. Interventional study of high dose folic acid in gastric carcinogenesis in beagles. Gut, 2002, 50: 61-64
[39]
39 Wang Y C, Wang J L, Kong X, et al. CD24, an early event of gastric carcinogenesis, induces gastric cancer progression via STAT3 activation. Apoptosis, 2013, doi: 10.1007/s10495-013-0949-9
[40]
40 Wang J L, Lin Y W, Chen H M, et al. Calcium prevents tumorigenesis in a mouse model of colorectal cancer. PLoS One, 2011, 6: e22566
[41]
41 Xu J, Wang J L, Xu B, et al. Colorectal cancer cells refractory to anti-VEGF treatment are vulnerable to glycolytic blockade due to persistent impairment of mitochondria. Mol Cancer Ther, 2013, 12: 717-724
[42]
42 Wu S, Lao X Y, Sun T T, et al. Downregulation of ZFX reduces the tumorigenicity of gastric cancer cells in vitro and in vivo via inhibiting the ERK-MAPK pathway. Cancer Lett, 2013, 337: 293-300
[43]
43 Chen H M, Yu Y N, Wang J L, et al. Decreased dietary fiber intake and structural alteration of gut microbiota in patients with advanced colorectal adenoma. Am J Clin Nutr, 2013, 97: 1044-1052
[44]
44 Zhu S, Mason J, Shi Y, et al. The effect of folic acid on the development of stomach and other gastrointestinal cancers. Chin Med J, 2003, 116: 15-19
[45]
45 Gao Q Y, Chen H M, Chen Y X, et al. Folic acid prevents the initial of sporadic colorectal adenoma in the elderly: a randomized clinical trial. Cancer Prev Res, 2013, 6: 744-752
